+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Pathway to Stop Diabetes - Accelerator Award (ACE)

American Diabetes Association, Inc.

Accelerator Award Description: This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.

Funding Support: Accelerator Awards provide research support of up to $325,000 USD per year (including 30% indirect costs) over five (5) years for a maximum total of $1,625,000 USD.

AI Based Application Success Predictor

1. Alignment with ADA Research Strategy

ADA favors investigator-initiated research that addresses diabetes prevention, treatment, complications, or cure

Highest priority is given to proposals with the potential for high clinical or translational impact—especially those that can influence patient outcomes or public health practices .

🧬 2. Innovation & High-Risk/High-Reward Potential

Programs like Pathway to Stop Diabetes, Accelerator, and Initiator Awards aim to fund bold, original ideas with transformative potential

Reviewers look for compelling novelty—e.g., new interorgan communication mechanisms or tech-driven glycemic tools

👩‍🔬 3. Investigator Track Record & Career Stage

Early-career focus: strongest emphasis on postdocs transitioning to independence (Initiator) and junior faculty (Accelerator, Junior Faculty Development)

Successful candidates show solid track records: publications, pilot data, prior grants—often leading to sustained funding and leadership positions .

📅 4. Commitment & Protected Time

Depending on the award, applicants must dedicate 75–100% effort during Phase I, and 25–75% in later stages .

Institutional nomination and strong support are required—proposals can't be submitted individually .

🌐 5. Mentorship & Institutional Support

Programs like Pathway pair awardees with world-renowned mentors to guide research and career development .

Robust institutional backing—labs, resources, training environment—is essential .

📊 6. Expected Impact & Sustainability

Reviewers assess potential to move from preliminary data to independent funding or implementation.

A 2005 cohort supported by ADA had 85% securing further funding within 5 years

✅ 7. Strong Administrative Planning

Administratively, grantees must deliver on: progress reports, financial reports, final reports, and publication/patent disclosures professional.diabetes.org.

Timeliness and compliance in reporting strengthen credibility for future awards.

🏆 Top Predictors at a Glance:

Predictor	Why It Matters
Mission alignment	Projects must fit ADA’s priorities (impact, innovation)
Innovation & novelty	Bold, high-risk ideas are favored
Early-career readiness	Strong for Phase‑1 and transition-focused awards
Track record	Publications/pilot data signal feasibility & capability
Institutional/mentor support	Essential for project success and nomination
Protected effort	Ensures focus and deliverables
Post-award performance	Publications, further funding, compliance boost renewals

🔧 Pro Tips for Applicants

Tailor to mission – clearly link your project to ADA’s current strategic priorities.

Show novelty & impact – emphasize high-risk ideas with translational promise.

Highlight readiness – include strong publications and pilot data.

Secure support – institutional nomination, mentorship plans, and defined effort commitment.

Plan for sustainability – outline steps for future grant success.

Ensure administrative readiness – commit to timely reporting and compliance.

Specialties

Diabetes

Endocrinology and Diabetes

Eligibility Requirements

Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Sponsor Details

Sponsor Institute/Organizations: American Diabetes Association, Inc.

Sponsor Type: Corporate/Non-Profit

Address: 2451 Crystal Drive, Suite 900 Arlington, VA 22202‑4804, USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity